These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23253254)

  • 41. Aggressive surgery in the multimodality treatment of liver metastases from colorectal cancer.
    Belev N; Takorov I; Dimov P; Vladov N; Penov V
    J BUON; 2007; 12(2):209-13. PubMed ID: 17600874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Timing of resection in patients with colorectal carcinoma and synchronous liver metastases].
    Hopt UT; Drognitz O; Neeff H
    Zentralbl Chir; 2009 Sep; 134(5):425-9. PubMed ID: 19757342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
    Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chemotherapy with curative intent before (neoadjuvant) or after (adjuvant) surgery for colorectal cancer liver metastases].
    Rougier P; Guimbaud R; Mitry E; Vaillant JN
    Bull Acad Natl Med; 2003; 187(5):881-92. PubMed ID: 14979053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
    Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combined surgical and oncological management of colorectal liver metastases].
    Bergenfeldt M; Jensen BV
    Ugeskr Laeger; 2008 Apr; 170(16):1353-6. PubMed ID: 18433598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
    Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
    Ychou M; Rivoire M; Thezenas S; Quenet F; Delpero JR; Rebischung C; Letoublon C; Guimbaud R; Francois E; Ducreux M; Desseigne F; Fabre JM; Assenat E
    Ann Surg Oncol; 2013 Dec; 20(13):4289-97. PubMed ID: 23955585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Sabanathan D; Eslick GD; Shannon J
    Clin Colorectal Cancer; 2016 Dec; 15(4):e141-e147. PubMed ID: 27174607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.
    Ruers TJ; Joosten JJ; Wiering B; Langenhoff BS; Dekker HM; Wobbes T; Oyen WJ; Krabbe PF; Punt CJ
    Ann Surg Oncol; 2007 Mar; 14(3):1161-9. PubMed ID: 17195903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Surgical therapy of colorectal liver metastases].
    Petrowsky H; Clavien PA
    Praxis (Bern 1994); 2005 Dec; 94(49):1943-8. PubMed ID: 16416927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Resectable colorectal liver metastases: pro neoadjuvant therapy - contra neoadjuvant therapy].
    Arnold D; Stöltzing O; Timm S; Stein A; Geissler M; Lang H
    Z Gastroenterol; 2010 Dec; 48(12):1375-83. PubMed ID: 21125514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A clinical study on multi-disciplinary team and surgery for resectable colorectal cancer with liver metastases].
    Yao HW; Xiu DR; Fu W; Yuan J; Jiang B; Wang DC; Ma CL; Yuan CH; Sun T; Ma LW; Cao BS; Liu JY; Chen M; Chen W; Tan S; Huang YH; Zhang L; Shi XY
    Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):961-5. PubMed ID: 23302476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
    Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S;
    Oncology; 2013; 84(1):14-21. PubMed ID: 23076023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: an exploratory study.
    Slesser AA; Khan F; Chau I; Khan AZ; Mudan S; Tekkis PP; Brown G; Rao S
    Eur J Surg Oncol; 2015 Apr; 41(4):484-92. PubMed ID: 25638603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.
    Small RM; Lubezky N; Shmueli E; Figer A; Aderka D; Nakache R; Klausner JM; Ben-Haim M
    J Surg Oncol; 2009 Feb; 99(2):93-8. PubMed ID: 19065637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
    Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
    ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgery combined with oncological treatments in liver metastases from colorectal cancer.
    Isoniemi H; Osterlund P
    Scand J Surg; 2011; 100(1):35-41. PubMed ID: 21482503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.